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 ABSTRACT
At present, mostly in Western countries, age is no longer an absolute limitation for renal replacement therapy 
(RRT); however, some elderly patients are still not considered for peritoneal dialysis (PD), mainly due to late refer-
ral, social isolation, low functional capacity or lower life expectancy. In this review, we address the challenges 
posed by older patients on PD programs, focusing on a SWOT (strengths, weaknesses, opportunities and threats) 
analysis and illustrate how PD may have successful outcomes in this population, worldwide and in Portugal. Finally, 
we will enumerate strategies to overcome the barriers to this technique. From January to December 2017, we 
conducted a systematic review of the literature using MEDLINE, the Cochrane Library and Web of Knowledge. 
Studies on PD and HD were included. All searches were limited to English and Portuguese and were augmented 
by review of bibliographic references from the studies included. Findings concerning modality superiority and 
better outcome in older people are still scarce and controversial, however according to several well-established 
PD programs worldwide, including assisted PD, elderly patients presented similar technique survival, hospitaliza-
tion rates and frequency of peritonitis as compared to younger PD patients and HD patients. As expected, older 
patients had higher mortality though, especially in patients with more comorbidities. On the other hand, PD was 
associated with less cognitive loss and showed benefit in perceived quality of life. In Portugal, the low utilization 
of PD and the patients’ age discrepancy between both modalities explains the limited literature and the discrepant 
results (some studies show lower peritonitis rate, superior technique and patient survival and others present 
higher hospitalization episodes and mortality rates); however, it appears to be a good (cost-effective) option for 
elderly patients. Overall, PD is an equally suitable modality for elderly patients in the long term. 
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 INTRODUCTION
Over the past 40 years, the world’s population has 
been aging at a rapid pace as a result of dramatic 
improvements in life expectancy, especially in developed 
areas. With patients reaching older age groups, the 
increasing incidence and prevalence of chronic diseases 
such as chronic kidney disease (CKD) pose new chal-
lenges to health professionals. 
CKD represents a significant international public 
health burden with rising economic cost, morbidity and 
mortality1. Overall, its prevalence is estimated to be 
8–16% (mean 11%) particularly high in developed areas 
such as Europe, the USA, Canada and Australia2,3but it 
frequently affects mostly the elderly, with age per se a 
risk factor for CKD. In people over 70 years of age, the 
prevalence of CKD stages 3–5 is 25%, and 30% in those 
over 80 years old4. In 2015, there were 901 million peo-
ple worldwide aged 60 years or over and 125 million 
older than 805,6. 
Similar trends apply to Portugal, which during the 
last few decades has faced a steep decline in birth rates 
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and a rapid growth of the aging population, resulting 
in a marked increase in the number of elderly and very 
elderly people (>80 years old). In 2015, 20.5% of our 
population was over 65 years old and increasing5. 
According to the ERA-EDTA Registry Annual Report, in 
2015, 81 373 individuals commenced renal replacement 
therapy (RRT) for end stage renal disease (ESRD) equat-
ing to an overall unadjusted incidence rate of 119 per 
million population (pmp). By the end of 2015, 546 783 
individuals were receiving RRT, corresponding to an 
unadjusted prevalence of 801 pmp. Portugal ranked 
second regarding incidence (227 pmp) and, first regard-
ing prevalence of RRT (1824 pmp) in Europe and was 
among the highest in the world7. Additionally, the 
Report Registry Office of the Portuguese Society of 
Nephrology (PSN) revealed that by the end of 2015, 18 
928 patients were on RRT; 61% (n= 11514) were on 
hemodialysis (HD); 35% (n= 6663) were transplanted 
and only 4% (n=751) were on peritoneal dialysis (PD) 
(2.5% patients above 65 years)8,9. 
This scenario calls for innovative approaches of health 
services, in order to guarantee quality and accessibility, 
allowing a more tailored prescription. But the question 
is not just quantitative – why aren’t more elderly patients 
on PD?. The question is primarily qualitative – are elderly 
patients receiving the treatment they aim for? Yet 
another matter remains – are the most tailored prescrip-
tion costs sustainable?
Despite domiciliary renal replacement regimens 
being increasingly advocated to overcome the economic 
burden of treating chronic diseases, there are many 
barriers to such a strategy. HD programs have grown 
exponentially with an unprecedented number of 
patients receiving dialysis, mainly in facility-based cent-
ers where healthcare professionals provide all the 
treatment. 
On the other hand, PD has remained an underused 
modality in all age groups10,11, mostly in older people 
who represent the fastest-growing group initiating 
dialysis12,13and despite PD being available worldwide 
and offering similar or even better overall survival when 
compared to HD14. Average PD penetration is reported 
to be 11–13% according to references, although con-
siderable variation exists among countries15-17. Despite 
only 4% of the Portuguese ESRD population being on 
PD in 2015, a tremendous growth in PD utilization was 
documented from 1997 to 2015 as a result of growing 
awareness among health professionals18. However, as 
opposed to its overall increase over the last decade, it 
is declining in developed countries15. Some reasons may 
explain the preference for HD over PD regardless of the 
good outcomes in older individuals, such as the lack of 
enthusiasm for PD and the absence of political invest-
ment which almost devaluate its effectiveness. While 
there are limited studies in the elderly, it has recently 
been shown that PD is an equally suitable modality for 
elderly patients in the long-term18-20 . With this in mind, 
it seems that overcoming the barriers to self-care PD in 
an aging population is a very important factor21.
Countries such as France and Hong Kong have shown 
that PD programs, especially assisted PD (asPD) may 
succeed in the elderly with minimal risk to overall health. 
Other countries such as Denmark, Canada, Italy, Brazil, 
Belgium, the UK, the Netherlands and China have also 
developed strategies to implement asPD (both continu-
ous ambulatory PD and automated PD) as clinical out-
comes have been shown to be promising in this age 
group22. However, this is only possible due to healthcare 
insurance and/or public healthcare systems which fully 
cover these programs. Worldwide governments should 
therefore develop health policies in order to accom-
modate the needs of this particular group.
  SPECIAL CONSIDERATIONS  
IN THE ELDERLY 
The elderly population has a unique profile of medical 
and social needs that must be addressed carefully with 
tailored risk and benefit calculations. Older individuals 
often have a higher incidence of comorbidities, prior 
surgery and geriatric syndromes such as frailty (weight 
loss, slow gait, fatigue, muscle weakness and functional 
impairment) impaired vision, deafness and cognitive 
dysfunction that predispose to increased morbidity and 
mortality. All these clinical conditions are associated 
with isolation, poor accommodation and financial prob-
lems13. However, these should not be interpreted as 
absolute contraindications to PD as nearly two-thirds 
of patients above age 65 are still capable of performing 
PD independently23. Being 65 years old nowadays is 
completely different from a century ago, when medical 
services were scarce and even less available to a popula-
tion which suffered severe illness and experienced pre-
mature death.  It is important to notice that at the 
present time, most people of this age still work on a 
regular basis and fully enjoy their independence. Even 
in older age groups, patients’ preference for independ-
ence and quality of life (QoL) spending more time at 
home with family and friends and practicing their regular 
hobbies could be more important than living some extra 
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amount of time on RRT. To fit treatments to patient 
expectations should be a major objective, particularly 
in the elderly.
  DIALYSIS MODALITY CHOICE  
FOR ELDERLY: A SWOT ANALYSIS 
Both HD and PD are suitable techniques for older 
populations, although there is a large disparity in the 
results of studies evaluating outcomes of PD vs HD. 
Globally, clinical results in PD are similar or better, not 
worse. Here, we focus on the benefits and challenges 
of PD for end-stage renal disease (ESRD) elderly 
patients, especially asPD, which is intended for those 
who cannot perform home self-dialysis but might ben-
efit from it. Table 1 summarizes the dialysis modality 
choices for the elderly based on SWOT analysis.
 Strengths
PD is widely accessible, even in the most remote 
and rural areas, including in the developing world, refut-
ing the myth that strict home conditions are mandatory. 
Moreover, indications and contraindications for PD in 
the elderly are similar to those existing in their younger 
counterparts, which makes it an accessible modality 
for this population. Additionally, some studies have 
demonstrated similar outcomes regarding mortality, 
morbidity and QoL in elderly people on PD and 
HD24,25,26. Others report a better sense of well-being 
and QoL, especially regarding patients’ mental states, 
which is directly related to the possibility of a more 
active social life with less treatment-schedule life intru-
sion, allowing them to better enjoy their free time with 
their family and friends23,25,27. Furthermore, it was 
documented that the elderly may suffer less cognitive 
loss under PD than HD28. Patients on PD benefit from 
better cardiovascular stability (fewer arrhythmias and 
hypotensive events, less variation in volume status and 
electrolyte shifts), better preservation of residual renal 
function, lower risk of gastrointestinal bleeding (no 
anticoagulation) and often less restricted diet29,30,31. 
Further, a native vascular access is often problematic 
in older patients, who are more likely to experience 
vascular access complications and the burden of vas-
cular procedures, so that the decision to place a central 
venous catheter must be counterbalanced with the 
viability of PD.
Moreover, this group of patients tend to begin dialy-
sis with higher residual renal function and diuresis 
which can be protected longer in contemporary PD 
incremental regimens.
Peritoneal Dialysis in the elderly: challenge accepted
Table 1
A SWOT analysis focused on Peritoneal Dialysis modality choice for the elderly: clinical and management issues
Strengths
• Home-based treatment 
• Better hemodynamic tolerance
• Lower risk of GI bleeding
• Longer renal function preservation 
• Less restricted potassium diet
• Lower treatment intrusion in life 
• Lower risk of cognitive loss 
• No need for vascular access 
• No need for iterative angioplasties /surgeries
• Fewer transport requirements
• Cheaper than center HD in some business models
Weaknesses
• Physical barriers 
• Cognitive barriers
• Psychological and social barriers
• Nephrologists´ lower experience with this modality
• Clinicians´ biased perceptions related with elderly and with PD
• Lack of job opportunities in PD 
• Lack of reimbursement incentives to PD
• Lack of integrated dialysis Units 
Opportunities
• Quality of life
• Flexibility and freedom
• Incremental PD
• Assisted PD
• Integrated dialysis care
• Telemedicine
• End-of-life comfort promotion
• Cost efficiency in dialysis access management 
• Cost-efficiency in transfer policies among modalities
Threats
• Isolation
• Technique failure
• Infections
• Minimal nurse training
• Caregiver burnout
• Conflict of interests within HD/PD Units
• Inadequate business model making modality costlier that HD
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Finally, when considering economical aspects, PD 
appears to be cheaper than HD when transportation 
cost to the HD center is allocated14. Depending on the 
business model, the cost of regular assistance by trained 
personnel (asPD) might be mitigated22. 
 Weaknesses
Most patients are eligible for PD but still nowadays, 
many nephrologists have little experience dealing with 
this type of RRT and neglect its advantages or indica-
tions. The great majority still feel uncomfortable with 
PD prescription and prefer a corporative HD work in 
clinics with appropriate therapy algorithms and high 
accessibility. Equally relevant is the fact that most of 
them tend to forget about this technique, due to both 
the absence of implemented structures to perform 
asPD safely and also the absence of allocated reim-
bursement, which definitely plays a negative role13.
A successful PD program with fewer complications 
is only possible if healthcare professionals and those 
who provide assistance to patients while they are per-
forming PD have adequate training, knowledge and 
reimbursement. Clinicians should be prepared to iden-
tify and overcome obstacles such as physical, cognitive, 
psychological or social barriers. Physical barriers such 
as decreased vision, strength, manual dexterity or 
mobility as well as cognitive barriers such as dementia, 
psychiatric conditions, learning disabilities or language 
barriers and finally, psychological barriers such as fear 
of lack of supervision, fear of isolation at home or feel-
ing overwhelmed by the possibility of performing home 
dialysis will all impact on the allocation to PD13. 
Indeed, some elderly experience loneliness and 
social isolation being more likely to decline and die 
faster in a way that going to an HD center on a regular 
basis might be an opportunity to socialize with 
others.
Therefore, both patients and medical professionals 
should be aware that dialysis may be burdensome and 
not always confer survival benefit (although this applies 
whichever the modality). It requires a thoughtful and 
individualized evaluation before starting RRT.
 Opportunities
To fully respect ethical recommendations, PD should 
be presented to all candidates to RRT so they can 
choose freely which modality suits them better21. How-
ever, we must anticipate that some patients will require 
personal assistance. Hence, asPD can be provided by 
family members, friends, home caregivers, healthcare 
professionals or skilled nurses/facilities. This approach 
has increased PD utilization mostly in developed coun-
tries such as Belgium, Canada, Denmark and France 
who have developed asPD programs to allow more 
patients to receive home dialysis with a gradual better 
quality of life, flexibility and freedom32. Patient empow-
erment as well as family and social support often over-
comes barriers perceived by the clinicians. Assisted PD 
is often needed in the short period after PD induction 
or hospital admission as a temporary support that is 
soon dispensed with as the patient gains self-confi-
dence and recovers.
The authors believe that telemedicine, a tool already 
applied in contemporary PD clinics, could provide clini-
cal supervision while mitigating patients’ and families’ 
sense of isolation. It should however be evaluated by 
the health business model to improve efficacy without 
threatening quality. 
Additionally, contrary to the present policies, it might 
be opportune to include the PD unit in an integrated 
dialysis clinic (with HD and PD, home and center modali-
ties) that would allow a better and more cost-efficient 
flux of patients among modalities in case of certain 
events such as indication to transfer, helper or patient 
burn-out, to provide guidance to familiar staff in access 
management and change of modality these would be 
easier and potentially less costly. This would allow the 
elderly to profit from the chosen home modality, giving 
him more confidence and support in his often limited 
living expectancy. Further, comfort-adjusted PD regi-
mens are feasible and appropriate for patients facing 
end-of-life complications, avoiding the clinical and 
financial burden of vascular accesses and intermittent 
extracorporeal sessions in clinics.
 Threats
Like any other type of RRT, PD may have potential 
problems, particularly in older patients who present 
more socio-economic barriers to self-care, fear of isola-
tion and of being unable to perform the technique, 
and risk of peritonitis33. Despite several studies showing 
infection rates to be similar in elderly vs non-elderly 
PD patients, peritoneal infections are associated with 
greater mortality in this age-group12,23,31,33. For this 
reason, it is very important to provide adequate training 
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to healthcare technicians, community nurses or family 
members who will be the patients’ caregiver to avoid 
these complications. 
Additionally, assisted PD may be associated with the 
risk of helper burn-out if adequate support is not 
given.
Considering organizational variables, even within 
integrated dialysis units, some conflict of interest may 
occur, threatening an unbiased allocation of patients 
to the modality. Finally, an economically successful 
business model in HD is a major competitive barrier to 
innovative models. 
  IS THERE EVIDENCE OF WORSE 
OUTCOMES WITH PD IN THE 
ELDERLY? NO
Findings on modality superiority in older people are 
still scarce, heterogeneous and controversial, showing 
rather discordant conclusions. These probably result 
from the lack of a standard definition of “elderly patient”, 
from numerous methodological issues not taking into 
account competing events’ risk analysis (death and 
access to kidney transplantation) and mostly from 
research centre effect34. 
Despite the heavy burden of comorbidities such as 
diabetes mellitus, arterial hypertension, dyslipidemia 
and neoplasia, data from more recent reports appear 
to be encouraging in this subgroup of patients28. As a 
matter of fact, it seems possible that elderly can attain 
favorable survival and quality of life similar to their 
younger counterparts35. Nonetheless, a very important 
factor to consider regarding long-term outcome is the 
hospitalization rate which is a significant marker of 
morbidity33. 
According to several reports from asPD programs 
from various world-centers, the number of hospital 
admissions was higher during the first year of treatment 
and more frequent in asPD compared to autonomous 
PD patients (35 vs 19 hospital days/patients.years) pre-
sumably related to the morbidity of assisted patients22,6. 
Two other studies from Oliver et al. and Quinn et al 
compared PD to In-Centre HD and demonstrated similar 
rates of all-cause hospitalization37,38. On the contrary, 
one study in United States showed that patients on 
domiciliary HD spend fewer days in the hospital than 
do PD patients39. However, these studies were all in 
younger patients. Regarding technique survival, a study 
in China found no difference between the younger and 
elderly patient groups35.
In South Korea, a prospective observational nation-
wide study was conducted to compare the outcome of 
elderly PD patients with elderly HD patients and younger 
PD Patients. The overall outcomes were similar between 
elderly PD and HD patients. PD showed benefit in QoL 
in the elderly. Additionally, the technical survival rate 
of elderly PD patients was similar to that of younger PD 
patients. Taken together, PD may be a comparable 
modality for elderly ESRD patients40.
Another study compared the outcome of older non-
diabetic patients (>70 y) with younger diabetic patients 
(40-60y) on continuous ambulatory PD (CAPD); survival 
rate at 2 years was significantly lower in the older group 
(68 vs 82%, p≤0.001) but the technique survival was 
similar (86 vs 88%) despite the higher peritonitis rate 
in the former group (0.52 vs 0.37 patient-year, p<0.002)41. 
In United Kingdom, Brown et al. found that in her 
own practice in 2002, 1-year and 4-year survivals for 
patients over 65 years old on CAPD and automated 
peritoneal dialysis (APD) were 94% and 63%13. At the 
same time, data from the UK Renal Registry report for 
2003 showed survival for all patients over 65 on dialysis 
(HD and PD) of 69% at 1 year and 33% at 4 years42. In 
contrast, the North Thames Dialysis Study (NTDS) report-
ed a 1-year survival rate of 71% for patients aged >70 
and mortality was significantly associated with age 80 
and older43. 
Kadambi et al. compared the outcomes of three 
groups of patients of different ages (<50 years, 50–64 
years and >65 years); 90% were on APD; patients over 
65 years of age had higher mortality rate but the rate 
of technique failure and overall peritonitis were not 
different from the younger individuals. Not surprisingly, 
patient survival on PD was affected by the comorbidities 
assessed by the Charslon Comorbidity Index28,40. 
Infectious complications and cardiovascular disease 
were the most common causes of hospitalization and 
of death33. Regarding peritonitis, it is usually responsible 
for 20% of PD technique failure and results in an overall 
mortality rate of 2–6%, but these vary widely according 
to the Centre policies and experience44,45. There is a 
wide variation in global PD peritonitis rate ranging from 
0.06 episodes/ year in Taiwan to 1.66 episodes/year in 
Israel46,47. 
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In some reports, peritonitis rate was lower in asPD 
patients than in self-PD patients (1/28 vs 1/25 patient-
months) whereas in some others it was found to be the 
other way round (1/25 vs 1/30 patients/months)22. In 
the self-care PD patients the rate of peritonitis was 
1/24.9 patient months and in the assisted group, 1/ 
28.2 patient months48. 
A study from France, where asPD is well implanted, 
mentioned that the probability of being  peritonitis-free 
was higher in patients assisted by their family members 
compared to nurse-assisted PD patients22. However, 
these results were inverted when fully trained nurses 
from dialysis centers where providing the home visits. 
Despite the previously described barriers related with 
aging, a recent study from the French Peritoneal Dialysis 
Registry concluded that there was no association 
between ages greater than 75 and increased risk of 
peritonitis. Moreover, 1-year and 4-year patient survivals 
of 94% and 63%, respectively have been reported for 
patients over 65 years old in Hammersmith Hospital, 
UK, along with data from Hong Kong which shows sur-
vival of 88% and 56% at 2 and 5 years13,49. 
Overall, it appears that regarding technique and elderly 
patient survival, PD is not inferior to HD. Home-based 
dialysis seems to be associated with more satisfaction 
than center-dialysis13,29. However, it is difficult to draw 
conclusions based on these data due to the absence of 
a comparable group of similar age and comorbidities.
  ARE SUCH OUTCOMES DIFFERENT  
IN PORTUGAL? NO
Data for 2015 from the 2016 Annual Report of the 
PSN Registry showed that from 2007 to 2015 there was 
a 45.3% increase in PD utilization vs 27.4% in HD. Gener-
ally, PD patients are younger (mean age: 54.5 years) 
than the overall ESRD population (mean age: 67 years). 
This age discrepancy is more pronounced between 
65–80 years old (HD: 40.8% vs PD: 25.3%) and even 
more over 80 (HD: 20.6% vs PD: 3.3%)8. Mortality (non-
adjusted) in HD corresponded to 13.3% vs 5.3% in PD. 
This may justify the paucity of Portuguese PD studies 
in elderly patients;, the majority addressing outcomes 
in the global treated population.
A study from Hospital Geral Santo António in Porto 
described their 20-year PD experience with 312 patients, 
but only 27% were >60 years19. Rodrigues et al. showed 
a cumulative survival of 91, 74 and 55% at one, three 
and five years, respectively, similar to larger reports 
conducted in Europe and the US. Of note, it was high-
lighted in this paper that the good survival rates could 
be associated with a positive selection of the population, 
mainly because auto-dialysis capacity was a major pre-
requisite for PD initiation. The rate of peritonitis was 
1/30 patient.months and hospital admission was 4.8 
days/patient.year. Regarding peritonitis, Teixeira et al, 
documented that the probability of experiencing a first 
episode was higher in older patients and in females50.
The Coimbra Hospital and University analyzed data 
from 184 PD patients over a 20-year period (19% of 
patients were ≥65 years old)18. Over the follow-up 
period, of the 76 PD patients who switched from HD 
due to vascular access failure, 65.8% died, 13.2% 
received a kidney transplant (KT), and 9.2% returned to 
HD. These patients were significantly older (mean age 
58.4 ± 14.9 years) than those who chose PD as the first 
RRT (mean age 41.8 ± 14.7 years, p = 0.001), possibly 
explaining the difference in the outcome. A total of 91 
episodes (1.2episodes/patient) of peritonitis occurred 
with an overall rate of 0.31 episodes/ patient.year. Dur-
ing the observation period, 34.2% died while on PD. 
The leading cause of death was cardiovascular disease 
(46.0%). Infections not related to the PD technique were 
the cause of death in 17.5% patients and peritonitis in 
4.5%. Using univariate Cox regression analysis, diabetes 
mellitus, older age, and prior HD were associated with 
lower survival. 
Data from a Portuguese study conducted in 2013 
that enrolled 851 patients of all ages from 17 hospital 
units showed a global drop-out rate of 25% (n=216) due 
to transfer to HD (55.2%), kidney transplant (30.3%), 
death (14%) and finally renal function recovery (0.5%). 
Causes for HD transference were technical failure (33%), 
catheter-related infections (29%), non-compliance (9%) 
and mechanical problems (9%). Mortality was secondary 
to cardiovascular events (56.7%), infectious complica-
tions (15.6%) and malnutrition (15.6%)51. 
More recently and with focus on the elderly, Campos 
et al. evaluated the rate of PD dropout in different age 
and era cohorts of 525 patients (15% were ≥65 years 
old)20. Results showed that PD was the first option for 
older people in 48%; <15% of them were using asPD 
(with a family helper) and the incidence of transfer to 
HD in these patients occurred at a rate of 11 epi-
sodes/100 patients-year. However, increasing age was 
not responsible for a higher rate of dropout. Except for 
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disability to self-dialysis, all other causes of technique 
failure were less common in the elderly such as access-
related infection (46.4%), ultrafiltration failure (17.9%) 
and mechanical complications (10.7%).
An additional 10-year study from Hospital de Santa 
Cruz in Lisbon regarding the clinical outcomes of 17 
patients under asPD were examined52. Assisted patients 
had lower peritonitis rate (0.4 vs 0.59 episodes/patient.
year), higher hospitalization episodes (0.67 versus 0.45 
episodes/patient.year, p=NS), superior technique sur-
vival (92.3%, 92.3%, 83.1%, 72.7% vs 91.9%, 81.7%, 
72.1%, 68.3%, at 1, 2, 3, and 4 years, respectively, p=NS) 
and similar patient survival (93.3%, 93.3%, 93.3%, 74.7% 
vs 95.9% 93.7%, 89%, 82% at 1, 2, 3, and 4 years, respec-
tively, p=NS). Based on these results, the authors con-
cluded that asPD offers an opportune, reliable, and 
effective homecare alternative for patients with no other 
RRT options.
Lastly, Coentrão et al. analysed the cost of HD and 
PD access in incident dialysis patients, suggesting that 
those who initiate PD require fewer resources to estab-
lish and maintain a dialysis access during the first year 
of treatment, emphasizing that PD is a cost-effective 
option53.
Along with these results, the majority of hospital PD 
units from North to South have progressively started to 
promote asPD to patients who are suitable for home-
based PD but unable for self-care, as an alternative to 
HD. However, home visits from healthcare professionals 
are still not covered by the public healthcare system, 
so assistance is provided by family members or close 
relatives. Public hospital policies and corporate dialysis 
facilities lack investment in home therapy in this par-
ticularly demanding but predominant group of elderly 
CKD patients. Reimbursement policies have not yet 
integrated assisted dialysis as a tool to promote home 
dialysis instead of center HD dialysis. Health business 
models along with the public health mission to provide 
quality treatments should be complementary in order 
to suit patient demands while avoiding clinical and cost 
burden. It is therefore time for a change.
 STRATEGIC PLANS 
Dialytic treatment, whether HD or PD should be able 
to promote the best QoL possible in the limited expect-
ed life-time of this group of elder patients, regardless 
of their age, beliefs and economic and social status. 
However, we should keep in mind that dialysis is not 
an appropriate option for every patient if it does not 
provide minimal survival benefit with comfort. Indi-
vidualized shared decisions must be made against one-
fits-all allocations. 
New policies (Table 2) should be promoted to solve 
the proposed issues: 1) quantitatively – more elderly 
patients should benefit from PD advantages, mitigating 
the enormous discrepancy in modality allocation that 
occurs independently of age;, 2) qualitatively – elderly 
patients ideally should be receiving the treatment they 
aim for and not the compulsory allocation to HD due 
to system (not technique) limitation;, 3) health ministry 
investment should be put on adequate business models 
to accommodate tailored dialysis, either in public or 
private facilities.
Indeed, PD has been demonstrated to be an excel-
lent alternative to HD for any age group, and specifically 
in older patients. Assisted PD has changed the paradigm 
by exploring new options for dependent frail individu-
als: nurse dialysis unit staff can assist a pool of PD 
Peritoneal Dialysis in the elderly: challenge accepted
Table 2
Strategic recommendation to promote PD
Government policies and economic factors
• Reimbursement incentives to healthcare provider/helper
• Initiatives to promote care within residential and nursing home settings
• Encourage of local manufacturing or production of PD solutions
• Creative business plans 
Healthcare professionals’ education
• Training of fellows, nephrologists, nurses and dialysis staff on 
 – the different dialysis modalities
 –  management of pain, depression, renal-specific symptoms and care at the 
end of life
Modality-related factors
• Shared decision making
• Updated access complications prevention 
• Updated use of PD regimens
• Optimized patient flux among modalities
Patient-related factors 
• Pre-dialysis education
• Creation of facilities that provide PD, patient-centered clubs, social activities
• Society commitment to aging groups
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patients sparing vascular access complications/proce-
dures, and transportation. The cost of PD solutions 
would follow the same scale economy advantages 
observed with HD variables. A PD-first program, or a 
PD-before vascular access in patients with reasonable 
life expectancy must be addressed: government policies 
and economic factors, modality and patient-related 
factors must be leveled and a business plan not neglect-
ing patient-first must be developed. Further, healthcare 
professional, patient or care provider education is the 
mainstay of this modality, playing a critical role in its 
success. In Hong Kong, Thailand and China, this was 
overcome by continuous education to fellows in train-
ing, nurses and dialysis staff, with massive public invest-
ment in PD which turned out to be clinically and finan-
cially attractive. In Portugal, all nephrologists in training 
have contact with PD for at least 3 to 6 months during 
their fellowship but then lose touch with this modality 
because jobs are offered mostly in HD clinics. This con-
text is beyond the medical advantages of home thera-
pies. Continuous registry of results, quality control and 
clinical investigation must be followed in dialysis units 
with straight link with economy experts to detail fields 
of improvement. Society must be also implied in poli-
cies: awareness, literacy and civil commitment to allow 
sustainability, equity and quality in health treatment.
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